Apoptotic effects of different drugs on cultured retinoblastoma Y79 cells

Tumor Biology

Volumn 19, Issue 5, 1998, Pages 356-363

  Lauricella, Marianna ^a   Giuliano, Michela ^a   Emanuele, Sonia ^a   Vento, Renza ^a   Tesoriere, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Apoptosis; Camptothecin; Cisplatin; Retinoblastoma cells; Sodium butyrate; Taxol

Indexed keywords

BUTYRIC ACID; CAMPTOTHECIN; CARBOPLATIN; CERAMIDE; CISPLATIN; DNA FRAGMENT; ETOPOSIDE; PACLITAXEL; PROTEIN P53;

APOPTOSIS; ARTICLE; DNA DAMAGE; DNA DEGRADATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RETINOBLASTOMA; TUMOR SUPPRESSOR GENE;

EID: 0031927472     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030028     Document Type: Article

References (38)

1. Vento R, Tesoriere G, Giuliano M, Calvaruso G, Lauricella M, Carabillò M: Synthesis of insulin and its effects in Y79 human retinoblastoma cells. Exp Eye Res 1994;59:221-229.
2. Giuliano M, Vento R, Lauricella M, Calvaruso G, Carabillò M, Tesoriere G: Role of insulin-like growth factors in autocrine growth of human retinoblastoma Y79 cells. Eur J Biochem 1996;236:523-532.
3. Reid TW, Albert DM, Rabson AS, Russel P, Craft J, Chu EW, Tralka TS, Wilcox JL: Characteristics of an established cell line of retinoblastoma. J Natl Cancer Inst 1974;53: 347-360.
4. Benedict WF, Murphree AL, Banerjee A, Spina CA, Sparkes MC, Sparkers RS: Patient with 13 chromosome deletion: Evidence that the retinoblastoma gene is a recessive cancer gene. Science 1983;219:973-975.
5. Hinds PW: The retinoblastoma tumor suppressor protein. Curr Opin Genet Dev 1995;5:79-83.
6. DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang CM, Livingstone DM: The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 1989;58:1085-1095.
7. Kaste SC, Chen G, Fontanesi J, Crom DB, Pratt CB: Orbital development in long-term survivors of retinoblastoma. J Clin Oncol 1997;15: 1183-1189.
8. Bornfeld N. Schuler A, Bechrakis N, Henze G, Havers W: Preliminary results of primary chemotherapy in retinoblastoma. Klin Pädiatr 1997; 209:216-221.
9. Shields CL, De Potter P, Himelstein BP, Shields JA, Meadows AT, Maris JM: Chemoreduction in the initial management of intraocular retinoblastoma. Arch Ophthalmol 1996; 114:1330-1338.
10. Kingston JE, Hungerford JL, Madreperla SA, Plowman PN: Results of combined chemotherapy and radiotherapy for advanced intraocular retinoblastoma. Arch Ophthalmol 1996;114:1339-1343.
11. Lee EY-HP, Chang CY, Hu NP, Wang YCI, Lai CC, Herrup K, Lee WH, Bradley A: Mice deficient for RB are nonviable and show defects in neurogenesis and hematopoiesis. Nature 1992;359:288-294.
12. White E: p53, guardian of Rb. Nature 1994;371:21-22.
13. Conway RM, Madigan MC, Penfold PL, Billson FA: Induction of apoptosis by sodium butyrate in the human Y-79 retinoblastoma cell line. Oncol Res 1995;7:289-297.
14. Inomata M, Saijo N, Kawashima K, Kaneko A, Fijiwara Y, Kunikane H, Tanaka Y: Induction of apoptosis in cultured retinoblastoma cells by the protein phosphatase inhibitor, okadaic acid. J Cancer Res Clin Oncol 1995;121:729-738.
15. Morris EJ, Geller HM: Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: Evidence for cell cycle-dependent toxicity. J Cell Biol 1996; 134:757-770.
16. Greenwald MJ, Strauss LC: Treatment of intraocular retinoblastoma with carboplatin and etoposide chemotherapy. Ophthalmology 1996; 103:1989-1997.
17. Rowinsky EK, Onetto N, Canetta RM, Arbuck SG: Taxol, the first of the taxanes, an important new class of antitumor agents. Semin Oncol 1992;19:648-662.
18. Firshing A, Nickel P, Mora P, Allolio B: Antiproliferative and angiostatic activity of suramin analogues. Cancer Res 1995;55:4957-4961.
19. Favoni RE, Ravera F, Pirani P, Ardizzoni A, Noonan D, de Cupis A: Suramin interferes with auto/paracrine insulin-like growth factor I-controlled proliferative loop on human lung cancer cell lines. Eur J Pharmacol 1994;264:199-206.
20. Kyritsis AP, Tsokos M, Chader GJ: Behavior of human retinoblastoma cells in tissue culture. Prog Retinal Res 1987;6:245-274.
21. Hannun YA, Obeid LM: Ceramide: An intracellular signal for apoptosis. Trends Biochem Sci 1995;20:73-77.
22. 3 in -HL60 cells. Role in cell differentiation. J Biol Chem 1989;264:19076-19080.
23. Leist M, Gartner F, Bohlinger I, Germann PG, Tiegs G, Wendel A: Murine hepatocyte apoptosis induced in vitro and in vivo by TNF-α requires transcriptional arrest. J Immunol 1994;153:1778-1788.
24. Sumantran VN, Ealovoga MW, Nunez G, Clarke MF, Wicha MS: Overexpression of Bcl-xs sensitizes MCF-7 cells to chemotherapy-induced apoptosis. Cancer Res 1995; 55:2507-2510.
25. Calvaruso G, Vento R, Gerbino E, Lauricella M, Carabillò M, Main H, Tesoriere G: Insulin and IGFs induce apoptosis in chick embryo retinas deprived of L-glutamine. Cell Death Differ 1997;4:209-215.
26. Martin SJ, Lennon SV, Bohnam AM, Cotter TG: Induction of apoptosis (programmed cell death) in human leukemic HL-60 cells by inhibition of RNA or protein synthesis. J Immunol 1990;145:1859-1867.
27. Hsiang Y-H, Hertzberg R, Hecht S, Liu LF: Camptothecin induces protein-linked DNA breaks via mammalian DNA topoisomerase I. J Biol Chem 1985;260:14873-14878.
28. Liu LF: DNA topoisomerase poisons as antitumor drugs. Annu Rev Biochem 1989;58:351-375.
29. Eastman A: Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro (ethylenediamine)platinum(II), Biochemistry 1983;22: 3927-3933.
30. Sorenson CM, Barry AM, Eastman A: Analysis of events associated with cell cycle arrest at G2 phase and cell death induced by cisplatin. J Natl Cancer Inst 1990;82:749-755.
31. Barry MA, Behnke CA, Eastman A: Activation of programmed cell death (apoptosis) by cisplatin, other anticancer drugs, toxins and hyperthermia. Biochem Pharmacol 1990; 40:2352-2362.
32. Chabner BA, Myers CE: Clinical pharmacology of cancer chemotherapy: in De Vita VTJ, Hellman J, Rosenberg SA (eds): Cancer: Principles and Practice at Oncology. Philadelphia, Lippincott, 1989, pp 349-395.
33. Schwartzman RA, Cidlowski JA: Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr Rev 1993;14: 133-151.
34. Steller H: Mechanism and genes of cellular suicide. Science 1995;267: 1445-1449.
35. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human Bax gene. Cell 1995;80:293-299.
36. Weintraub SJ, Prater CA, Dean DC: Retinoblastoma protein switches the E2F site from a positive to a negative element. Nature 1992;358: 259-261.
37. Chellapan SP, Hiebert S, Mudryi M, Horowitz JM, Kevins JA: The E2F transcription factor is a cellular target for the RB protein. Cell 1991;65: 1053-1061.
38. Macleod KF, Yanwen H, Jacks T: Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J 1996;15: 6178-6188.